Nine Chapters Capital Management’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-25,900
Closed -$1.65M 135
2015
Q3
$1.65M Sell
25,900
-6,000
-19% -$431K 0.14% 197
2015
Q2
$2.24M Buy
31,900
+16,400
+106% +$1.21M 0.19% 140
2015
Q1
$1.23M Sell
15,500
-1,000
-6% -$73.8K 0.1% 304
2014
Q4
$1.05M Sell
16,500
-17,300
-51% -$1.08M 0.09% 314
2014
Q3
$2.02M Sell
33,800
-31,200
-48% -$1.79M 0.18% 155
2014
Q2
$3.48M Buy
65,000
+53,300
+456% +$2.92M 0.28% 85
2014
Q1
$706K Sell
11,700
-27,700
-70% -$1.61M 0.08% 362
2013
Q4
$2.09M Sell
39,400
-8,200
-17% -$412K 0.21% 131
2013
Q3
$2.2M Buy
47,600
+1,800
+4% +$82.6K 0.26% 109
2013
Q2
$1.88M Buy
+45,800
New +$1.96M 0.32% 76

Other funds holding CRL